VAXCYTE

vaxcyte-logo

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Companyโ€™s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyteโ€™s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks o... f vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. In addition to its pneumococcal conjugate vaccines in development, VAX-24 and VAX-XP, Vaxcyte is leveraging its proprietary platform to advance other novel vaccines, including a prophylactic vaccine to prevent Group A Strep infections (VAX-A1) and a therapeutic vaccine to treat periodontal disease (VAX-PG).

#SimilarOrganizations #People #Financial #Event #Website #More

VAXCYTE

Social Links:

Industry:
Biopharma Biotechnology Delivery Service Health Care

Founded:
2013-12-01

Address:
Foster City, California, United States

Country:
United States

Website Url:
http://www.vaxcyte.com

Total Employee:
11+

Status:
Active

Contact:
(650) 837-0111

Email Addresses:
[email protected]

Total Funding:
384.54 M USD

Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare DNS WP Engine Dropbox Business


Similar Organizations

cache-logo

Cache

Cache is advancing personalized medicine and digital data storage by making storage and access to biomolecules widely accessible.

denteric-logo

Denteric

Denteric is developing a vaccine based on research conducted at the University of Melbourne.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.


Current Advisors List

agustin-mohedas_image

Agustin Mohedas Board Observer @ Vaxcyte
Board_observer
2020-03-01

annie-drapeau_image

Annie Drapeau Member Board Of Directors @ Vaxcyte
Board_member
2021-09-01

halley-gilbert_image

HALLEY GILBERT Board Member @ Vaxcyte
Board_member
2020-04-01

teri-loxam_image

Teri loxam Board Member @ Vaxcyte
Board_member
2021-09-01

halley-gilbert_image

HALLEY GILBERT Board Member; Chair Nominating & Governance Committee; Member, Audit Committee @ Vaxcyte
Board_member
2020-04-01

kurt-von-emster_image

Kurt von Emster Board Member @ Vaxcyte
Board_member
2015-07-01

derek-dirocco_image

Derek DiRocco Board Observer @ Vaxcyte
Board_observer
2020-03-01

Current Employees Featured

grant-e-pickering_image

Grant E. Pickering
Grant E. Pickering Co-Founder & CEO @ Vaxcyte
Co-Founder & CEO

moncef-slaoui_image

Moncef Slaoui
Moncef Slaoui Chairman @ Vaxcyte
Chairman

paul-w-sauer_image

Paul W. Sauer
Paul W. Sauer Senior Vice President, Process Development & Manufacturing @ Vaxcyte
Senior Vice President, Process Development & Manufacturing
2016-04-01

not_available_image

Jim Wassil
Jim Wassil COO @ Vaxcyte
COO

andrew-guggenhime_image

Andrew Guggenhime
Andrew Guggenhime President & Chief Financial Officer @ Vaxcyte
President & Chief Financial Officer
2021-01-01

jeff-fairman_image

Jeff Fairman
Jeff Fairman Founder & Vice President, Research @ Vaxcyte
Founder & Vice President, Research
2013-12-01

Founder


not_available_image

Ash Khanna

grant-e-pickering_image

Grant E. Pickering

jeff-fairman_image

Jeff Fairman

Stock Details


Company's stock symbol is NASDAQ:PCVX

Investors List

carb-x_image

CARB-X

CARB-X investment in Grant - Vaxcyte

carb-x_image

CARB-X

CARB-X investment in Grant - Vaxcyte

pivotal-bioventure-partners_image

Pivotal bioVenture Partners

Pivotal bioVenture Partners investment in Series D - Vaxcyte

longitude-capital_image

Longitude Capital

Longitude Capital investment in Series D - Vaxcyte

cti-life-sciences-fund-2_image

CTI Life Sciences Fund

CTI Life Sciences Fund investment in Series D - Vaxcyte

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series D - Vaxcyte

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series D - Vaxcyte

tpg-growth_image

TPG Growth

TPG Growth investment in Series D - Vaxcyte

foresite-capital_image

Foresite Capital

Foresite Capital investment in Series D - Vaxcyte

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series D - Vaxcyte

Key Employee Changes

Date New article
2020-01-30 SutroVax Announces Executive Appointment

Official Site Inspections

http://www.vaxcyte.com Semrush global rank: 1.66 M Semrush visits lastest month: 14.87 K

  • Host name: 141.193.213.21
  • IP address: 141.193.213.21
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Vaxcyte" on Search Engine